KOREAN biopharmaceutical company, Celltrion Healthcare, has indicated its intention to join Australia's Generic and Biosimilar Medicines Association (GBMA).
The company will be the first GBMA member to join the new internal subgroup, Biosimilar Membership.
GBMA Chief Executive Officer, Marnie Peterson, welcomed Celltrion Healthcare's engagement saying, "This is further evidence of the role that biosimilar medicines can play in ensuring a sustainable healthcare system for Australian patients, particularly for the Pharmaceutical Benefits Scheme".
The above article was sent to subscribers in Pharmacy Daily's issue from 19 Jul 19
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 19 Jul 19